Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × trastuzumab deruxtecan × Gynecologic × Clear all

Phase

Status

Recruiting 6 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 10 Tumor-Agnostic 2 Other solid neoplasm 1 Gynecologic 1 Gastrointestinal 1 CNS 1

Conditions

Recurrence 1 Ovarian Neoplasms 1

Interventions

Paclitaxel 21 Carboplatin 14 Cisplatin 12 Bevacizumab 11 fluzoparib 7 Brachytherapy 7 pembrolizumab 6 Drug Therapy 6 apatinib 5 Radiotherapy 5 Injections 5 lenvatinib 4 famitinib 4 Topotecan 4 Tirzepatide 4 Platinum 4 Observation 4 Neoadjuvant Therapy 4 toripalimab 3 olaparib 3 envafolimab 3 dostarlimab 3 camrelizumab 3 Platinum Compounds 3 Megestrol Acetate 3 zimberelimab 2 tislelizumab 2 sintilimab 2 niraparib 2 nimotuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07340164 2026-01-14

TROY

Yonsei University

Phase 2 Not yet recruiting

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡